APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antibody-drug Conjugates

Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.

Selected research

Market Structure

Global Antibody-drug Conjugates Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025175 pages

Choose your research edition.

Industry ResearchAntibody-drug Conjugates Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Antibody-drug Conjugates Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Antibody-drug Conjugates Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antibody-drug Conjugates Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Antibody-drug Conjugates Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.

North America is the largest market with about 59% market share. Europe is follower, accounting for about 27% market share.

The key players are ImmunoGen, Seattle Genetics, Roche, Takeda etc. Takeda is the largest manufacturer with about 57% revenue market share.

Read the full market overview

This report provides an overview of the global Antibody-drug Conjugates market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antibody-drug Conjugates and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antibody-drug Conjugates sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antibody-drug Conjugates market size, projected growth trends, production technologies, key applications, and end-use industries.

Antibody-drug Conjugates Segment by Company

ImmunoGen

Seattle Genetics

Roche

Takeda

Antibody-drug Conjugates Segment by Type

Adcetris

Kadcyla

Antibody-drug Conjugates Segment by Application

Breast Cancer

Lymphoma

Antibody-drug Conjugates Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibody-drug Conjugates market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antibody-drug Conjugates and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibody-drug Conjugates.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antibody-drug Conjugates market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antibody-drug Conjugates manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Antibody-drug Conjugates in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Antibody-drug Conjugates in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Antibody-drug Conjugates Industry Trends Table 2. Antibody-drug Conjugates Industry Drivers Table 3. Antibody-drug Conjugates Industry Opportunities and Challenges Table 4. Antibody-drug Conjugates Industry Restraints Table 5. Global Antibody-drug Conjugates Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Antibody-drug Conjugates Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Antibody-drug Conjugates Sales by Manufacturers (Kg) & (2021-2026) Table 8. Global Antibody-drug Conjugates Sales Market Share by Manufacturers Table 9. Global Antibody-drug Conjugates Average Sales Price (USD/Kg) of Manufacturers (2021-2026) Table 10. Global Antibody-drug Conjugates Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Antibody-drug Conjugates Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Antibody-drug Conjugates Manufacturers, Product Type & Application Table 13. Global Antibody-drug Conjugates Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Antibody-drug Conjugates by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Adcetris Table 17. Major Manufacturers of Kadcyla Table 18. Global Antibody-drug Conjugates Sales by Type 2021 VS 2025 VS 2032 (Kg) Table 19. Global Antibody-drug Conjugates Sales by Type (2021-2026) & (Kg) Table 20. Global Antibody-drug Conjugates Sales by Type (2027-2032) & (Kg) Table 21. Global Antibody-drug Conjugates Sales Market Share by Type (2021-2026) Table 22. Global Antibody-drug Conjugates Sales Market Share by Type (2027-2032) Table 23. Global Antibody-drug Conjugates Revenue by Type 2021 VS 2025 VS 2032 (Kg) Table 24. Global Antibody-drug Conjugates Revenue by Type (2021-2026) & (Kg) Table 25. Global Antibody-drug Conjugates Revenue by Type (2027-2032) & (Kg) Table 26. Global Antibody-drug Conjugates Revenue Market Share by Type (2021-2026) Table 27. Global Antibody-drug Conjugates Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Breast Cancer Table 29. Major Manufacturers of Lymphoma Table 30. Global Antibody-drug Conjugates Sales by Application 2021 VS 2025 VS 2032 (Kg) Table 31. Global Antibody-drug Conjugates Sales by Application (2021-2026) & (Kg) Table 32. Global Antibody-drug Conjugates Sales by Application (2027-2032) & (Kg) Table 33. Global Antibody-drug Conjugates Sales Market Share by Application (2021-2026) Table 34. Global Antibody-drug Conjugates Sales Market Share by Application (2027-2032) Table 35. Global Antibody-drug Conjugates Revenue by Application 2021 VS 2025 VS 2032 (Kg) Table 36. Global Antibody-drug Conjugates Revenue by Application (2021-2026) & (Kg) Table 37. Global Antibody-drug Conjugates Revenue by Application (2027-2032) & (Kg) Table 38. Global Antibody-drug Conjugates Revenue Market Share by Application (2021-2026) Table 39. Global Antibody-drug Conjugates Revenue Market Share by Application (2027-2032) Table 40. Global Antibody-drug Conjugates Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 41. Global Antibody-drug Conjugates Sales by Region (2021-2026) & (Kg) Table 42. Global Antibody-drug Conjugates Sales Market Share by Region (2021-2026) Table 43. Global Antibody-drug Conjugates Sales Forecasted by Region (2027-2032) & (Kg) Table 44. Global Antibody-drug Conjugates Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Antibody-drug Conjugates Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 46. North America Antibody-drug Conjugates Sales by Country (2021-2026) & (Kg) Table 47. North America Antibody-drug Conjugates Sales by Country (2027-2032) & (Kg) Table 48. Europe Antibody-drug Conjugates Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 49. Europe Antibody-drug Conjugates Sales by Country (2021-2026) & (Kg) Table 50. Europe Antibody-drug Conjugates Sales by Country (2027-2032) & (Kg) Table 51. Asia Pacific Antibody-drug Conjugates Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 52. Asia Pacific Antibody-drug Conjugates Sales by Country (2021-2026) & (Kg) Table 53. Asia Pacific Antibody-drug Conjugates Sales by Country (2027-2032) & (Kg) Table 54. South America, Middle East and Africa Antibody-drug Conjugates Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 55. South America, Middle East and Africa Antibody-drug Conjugates Sales by Country (2021-2026) & (Kg) Table 56. South America, Middle East and Africa Antibody-drug Conjugates Sales by Country (2027-2032) & (Kg) Table 57. Global Antibody-drug Conjugates Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Antibody-drug Conjugates Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Antibody-drug Conjugates Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Antibody-drug Conjugates Revenue Market Share by Region (2021-2026) Table 61. Global Antibody-drug Conjugates Revenue Market Share by Region (2027-2032) Table 62. ImmunoGen Company Information Table 63. ImmunoGen Business Overview Table 64. ImmunoGen Antibody-drug Conjugates Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. ImmunoGen Antibody-drug Conjugates Product Portfolio Table 66. ImmunoGen Recent Development Table 67. Seattle Genetics Company Information Table 68. Seattle Genetics Business Overview Table 69. Seattle Genetics Antibody-drug Conjugates Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Seattle Genetics Antibody-drug Conjugates Product Portfolio Table 71. Seattle Genetics Recent Development Table 72. Roche Company Information Table 73. Roche Business Overview Table 74. Roche Antibody-drug Conjugates Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Roche Antibody-drug Conjugates Product Portfolio Table 76. Roche Recent Development Table 77. Takeda Company Information Table 78. Takeda Business Overview Table 79. Takeda Antibody-drug Conjugates Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Takeda Antibody-drug Conjugates Product Portfolio Table 81. Takeda Recent Development Table 82. Key Raw Materials Table 83. Raw Materials Key Suppliers Table 84. Antibody-drug Conjugates Distributors List Table 85. Antibody-drug Conjugates Customers List Table 86. Research Programs/Design for This Report Table 87. Authors List of This Report Table 88. Secondary Sources Table 89. Primary Sources List of Figures Figure 1. Antibody-drug Conjugates Product Image Figure 2. Global Antibody-drug Conjugates Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antibody-drug Conjugates Market Size (2021-2032) & (US$ Million) Figure 4. Global Antibody-drug Conjugates Sales (2021-2032) & (Kg) Figure 5. Global Antibody-drug Conjugates Average Price (USD/Kg) & (2021-2032) Figure 6. Global Top 5 and 10 Antibody-drug Conjugates Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Adcetris Image Figure 9. Kadcyla Image Figure 10. Global Antibody-drug Conjugates Sales by Type (2021 VS 2025 VS 2032) & (Kg) Figure 11. Global Antibody-drug Conjugates Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Antibody-drug Conjugates Sales Market Share by Type (2021-2032) Figure 13. Global Antibody-drug Conjugates Revenue by Type (2021 VS 2025 VS 2032) & (Kg) Figure 14. Global Antibody-drug Conjugates Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Antibody-drug Conjugates Revenue Market Share by Type (2021-2032) Figure 16. Breast Cancer Image Figure 17. Lymphoma Image Figure 18. Global Antibody-drug Conjugates Sales by Application (2021 VS 2025 VS 2032) & (Kg) Figure 19. Global Antibody-drug Conjugates Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Antibody-drug Conjugates Sales Market Share by Application (2021-2032) Figure 21. Global Antibody-drug Conjugates Revenue by Application (2021 VS 2025 VS 2032) & (Kg) Figure 22. Global Antibody-drug Conjugates Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Antibody-drug Conjugates Revenue Market Share by Application (2021-2032) Figure 24. North America Antibody-drug Conjugates Sales and Growth Rate (2021-2032) & (Kg) Figure 25. North America Antibody-drug Conjugates Sales Market Share by Country (2021-2032) Figure 26. U.S. Antibody-drug Conjugates Sales and Growth Rate (2021-2032) & (Kg) Figure 27. Canada Antibody-drug Conjugates Sales and Growth Rate (2021-2032) & (Kg) Figure 28. Mexico Antibody-drug Conjugates Sales and Growth Rate (2021-2032) & (Kg) Figure 29. Europe Antibody-drug Conjugates Sales and Growth Rate (2021-2032) & (Kg) Figure 30. Europe Antibody-drug Conjugates Sales Market Share by Country (2021-2032) Figure 31. Germany Antibody-drug Conjugates Sales and Growth Rate (2021-2032) & (Kg) Figure 32. France Antibody-drug Conjugates Sales and Growth Rate (2021-2032) & (Kg) Figure 33. U.K. Antibody-drug Conjugates Sales and Growth Rate (2021-2032) & (Kg) Figure 34. Italy Antibody-drug Conjugates Sales and Growth Rate (2021-2032) & (Kg) Figure 35. Netherlands Antibody-drug Conjugates Sales and Growth Rate (2021-2032) & (Kg) Figure 36. Asia Pacific Antibody-drug Conjugates Sales and Growth Rate (2021-2032) & (Kg) Figure 37. Asia Pacific Antibody-drug Conjugates Sales Market Share by Country (2021-2032) Figure 38. China Antibody-drug Conjugates Sales and Growth Rate (2021-2032) & (Kg) Figure 39. Japan Antibody-drug Conjugates Sales and Growth Rate (2021-2032) & (Kg) Figure 40. South Korea Antibody-drug Conjugates Sales and Growth Rate (2021-2032) & (Kg) Figure 41. Southeast Asia Antibody-drug Conjugates Sales and Growth Rate (2021-2032) & (Kg) Figure 42. India Antibody-drug Conjugates Sales and Growth Rate (2021-2032) & (Kg) Figure 43. Australia Antibody-drug Conjugates Sales and Growth Rate (2021-2032) & (Kg) Figure 44. South America, Middle East and Africa Antibody-drug Conjugates Sales and Growth Rate (2021-2032) & (Kg) Figure 45. South America, Middle East and Africa Antibody-drug Conjugates Sales Market Share by Country (2021-2032) Figure 46. Brazil Antibody-drug Conjugates Sales and Growth Rate (2021-2032) & (Kg) Figure 47. South Africa Antibody-drug Conjugates Sales and Growth Rate (2021-2032) & (Kg) Figure 48. Saudi Arabia Antibody-drug Conjugates Sales and Growth Rate (2021-2032) & (Kg) Figure 49. Turkey Antibody-drug Conjugates Sales and Growth Rate (2021-2032) & (Kg) Figure 50. Argentina Antibody-drug Conjugates Sales and Growth Rate (2021-2032) & (Kg) Figure 51. UAE Antibody-drug Conjugates Sales and Growth Rate (2021-2032) & (Kg) Figure 52. Egypt Antibody-drug Conjugates Sales and Growth Rate (2021-2032) & (Kg) Figure 53. Chile Antibody-drug Conjugates Sales and Growth Rate (2021-2032) & (Kg) Figure 54. Global Antibody-drug Conjugates Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Antibody-drug Conjugates Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Figure 57. North America Antibody-drug Conjugates Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Figure 59. Europe Antibody-drug Conjugates Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Antibody-drug Conjugates Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Antibody-drug Conjugates Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Antibody-drug Conjugates Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Antibody-drug Conjugates Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Adcetris
  • Kadcyla
Applications
  • Breast Cancer
  • Lymphoma
Companies covered
  • ImmunoGen
  • Seattle Genetics
  • Roche
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Antibody-drug Conjugates Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Antibody-drug Conjugates Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Antibody-drug Conjugates Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Antibody-drug Conjugates Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Antibody-drug Conjugates Market Dynamics
  1. 2.1 Antibody-drug Conjugates Industry Trends
  2. 2.2 Antibody-drug Conjugates Industry Drivers
  3. 2.3 Antibody-drug Conjugates Industry Opportunities and Challenges
  4. 2.4 Antibody-drug Conjugates Industry Restraints
3 Antibody-drug Conjugates Market by Manufacturers
  1. 3.1 Global Antibody-drug Conjugates Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Antibody-drug Conjugates Sales by Manufacturers (2021-2026)
  3. 3.3 Global Antibody-drug Conjugates Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Antibody-drug Conjugates Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antibody-drug Conjugates Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Antibody-drug Conjugates Manufacturers, Product Type & Application
  7. 3.7 Global Antibody-drug Conjugates Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antibody-drug Conjugates Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antibody-drug Conjugates Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antibody-drug Conjugates Tier 1, Tier 2, and Tier 3
4 Antibody-drug Conjugates Market by Type
  1. 4.1 Antibody-drug Conjugates Type Introduction
  2. 4.1.1 Adcetris
  3. 4.1.2 Kadcyla
  4. 4.2 Global Antibody-drug Conjugates Sales by Type
  5. 4.2.1 Global Antibody-drug Conjugates Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Antibody-drug Conjugates Sales by Type (2021-2032)
  7. 4.2.3 Global Antibody-drug Conjugates Sales Market Share by Type (2021-2032)
  8. 4.3 Global Antibody-drug Conjugates Revenue by Type
  9. 4.3.1 Global Antibody-drug Conjugates Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Antibody-drug Conjugates Revenue by Type (2021-2032)
  11. 4.3.3 Global Antibody-drug Conjugates Revenue Market Share by Type (2021-2032)
5 Antibody-drug Conjugates Market by Application
  1. 5.1 Antibody-drug Conjugates Application Introduction
  2. 5.1.1 Breast Cancer
  3. 5.1.2 Lymphoma
  4. 5.2 Global Antibody-drug Conjugates Sales by Application
  5. 5.2.1 Global Antibody-drug Conjugates Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Antibody-drug Conjugates Sales by Application (2021-2032)
  7. 5.2.3 Global Antibody-drug Conjugates Sales Market Share by Application (2021-2032)
  8. 5.3 Global Antibody-drug Conjugates Revenue by Application
  9. 5.3.1 Global Antibody-drug Conjugates Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Antibody-drug Conjugates Revenue by Application (2021-2032)
  11. 5.3.3 Global Antibody-drug Conjugates Revenue Market Share by Application (2021-2032)
6 Global Antibody-drug Conjugates Sales by Region
  1. 6.1 Global Antibody-drug Conjugates Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antibody-drug Conjugates Sales by Region (2021-2032)
  3. 6.2.1 Global Antibody-drug Conjugates Sales by Region (2021-2026)
  4. 6.2.2 Global Antibody-drug Conjugates Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Antibody-drug Conjugates Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Antibody-drug Conjugates Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Antibody-drug Conjugates Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Antibody-drug Conjugates Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Antibody-drug Conjugates Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Antibody-drug Conjugates Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Antibody-drug Conjugates Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Antibody-drug Conjugates Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Antibody-drug Conjugates Revenue by Region
  1. 7.1 Global Antibody-drug Conjugates Revenue by Region
  2. 7.1.1 Global Antibody-drug Conjugates Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Antibody-drug Conjugates Revenue by Region (2021-2026)
  4. 7.1.3 Global Antibody-drug Conjugates Revenue by Region (2027-2032)
  5. 7.1.4 Global Antibody-drug Conjugates Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Antibody-drug Conjugates Revenue (2021-2032)
  8. 7.2.2 North America Antibody-drug Conjugates Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Antibody-drug Conjugates Revenue (2021-2032)
  11. 7.3.2 Europe Antibody-drug Conjugates Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Antibody-drug Conjugates Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Antibody-drug Conjugates Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Antibody-drug Conjugates Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Antibody-drug Conjugates Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 ImmunoGen
  2. 8.1.1 ImmunoGen Company Information
  3. 8.1.2 ImmunoGen Business Overview
  4. 8.1.3 ImmunoGen Antibody-drug Conjugates Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ImmunoGen Antibody-drug Conjugates Product Portfolio
  6. 8.1.5 ImmunoGen Recent Developments
  7. 8.2 Seattle Genetics
  8. 8.2.1 Seattle Genetics Company Information
  9. 8.2.2 Seattle Genetics Business Overview
  10. 8.2.3 Seattle Genetics Antibody-drug Conjugates Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Seattle Genetics Antibody-drug Conjugates Product Portfolio
  12. 8.2.5 Seattle Genetics Recent Developments
  13. 8.3 Roche
  14. 8.3.1 Roche Company Information
  15. 8.3.2 Roche Business Overview
  16. 8.3.3 Roche Antibody-drug Conjugates Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Roche Antibody-drug Conjugates Product Portfolio
  18. 8.3.5 Roche Recent Developments
  19. 8.4 Takeda
  20. 8.4.1 Takeda Company Information
  21. 8.4.2 Takeda Business Overview
  22. 8.4.3 Takeda Antibody-drug Conjugates Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Takeda Antibody-drug Conjugates Product Portfolio
  24. 8.4.5 Takeda Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Antibody-drug Conjugates Value Chain Analysis
  2. 9.1.1 Antibody-drug Conjugates Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Antibody-drug Conjugates Production Mode & Process
  6. 9.2 Antibody-drug Conjugates Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Antibody-drug Conjugates Distributors
  9. 9.2.3 Antibody-drug Conjugates Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst